Top Pharmaceutical Companies Trust PharmaLegacy for their Immunology Studies
Non-human primates (NHP) share significant homology with humans allowing cross reactivity with biologic, cell and gene-based therapies. This permits testing of your treatment without the need to generate a costly rodent surrogate. Additionally, your therapies physiological and histological effects are more likely to be faithfully recapitulated compared to rodent systems.
Download our “Non-Human Primate Models for Immunological Research” brochure to learn more about the many validated models PharmaLegacy offers and see real-world sample data.